APLS | | Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Director | Mar 19, 2024 | Sale | $57.18 | 18,681 | 1,068,161 | 173,998 | Mar 20, 2024, 05:18 PM |
APLS | | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Mar 18, 2024 | Sale | $56.90 | 9,913 | 564,050 | 54,693 | Mar 19, 2024, 04:03 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Chopas James George | VP/Chief Accounting Officer | Mar 15, 2024 | Sale | $56.46 | 184 | 10,389 | 38,883 | Mar 18, 2024, 04:19 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Mar 13, 2024 | Sale | $57.56 | 11,220 | 645,838 | 59,739 | Mar 14, 2024, 04:17 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Mar 08, 2024 | Sale | $32.93 | 138,214 | 4,551,172 | 1,185,090 | Mar 11, 2024, 04:08 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Mar 06, 2024 | Option Exercise | $13.85 | 3,762 | 52,104 | 107,152 | Mar 08, 2024, 07:45 AM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 01, 2024 | Sale | $34.16 | 500,000 | 17,078,706 | 563,662 | Mar 05, 2024, 04:07 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Mar 01, 2024 | Sale | $36.63 | 12,000 | 439,520 | 99,338 | Mar 05, 2024, 04:04 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Feb 12, 2024 | Sale | $67.77 | 781 | 52,926 | 103,390 | Feb 13, 2024, 05:06 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Feb 12, 2024 | Sale | $67.77 | 1,148 | 77,796 | 92,453 | Feb 13, 2024, 05:05 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Feb 12, 2024 | Sale | $67.77 | 1,431 | 96,974 | 93,338 | Feb 13, 2024, 04:59 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 12, 2024 | Sale | $67.77 | 3,962 | 268,492 | 313,662 | Feb 13, 2024, 04:49 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Feb 12, 2024 | Sale | $67.77 | 1,148 | 77,796 | 1,115,983 | Feb 13, 2024, 04:43 PM |
APLS | | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Feb 12, 2024 | Sale | $67.77 | 597 | 40,457 | 64,606 | Feb 13, 2024, 04:38 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Jan 29, 2024 | Sale | $64.14 | 906 | 58,109 | 104,171 | Jan 31, 2024, 04:38 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 29, 2024 | Sale | $64.14 | 906 | 58,109 | 93,601 | Jan 31, 2024, 04:36 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jan 29, 2024 | Sale | $64.14 | 906 | 58,109 | 94,769 | Jan 31, 2024, 04:34 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Jan 29, 2024 | Sale | $64.14 | 835 | 53,555 | 67,507 | Jan 31, 2024, 04:31 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Lewis Karen | Chief People Officer | Jan 29, 2024 | Sale | $64.14 | 367 | 23,539 | 47,270 | Jan 31, 2024, 04:28 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Lewis Karen | Chief People Officer | Jan 30, 2024 | Sale | $65.53 | 883 | 57,863 | 46,387 | Jan 31, 2024, 04:28 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 29, 2024 | Sale | $64.14 | 2,843 | 182,345 | 317,624 | Jan 31, 2024, 04:26 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Eisele Jeffrey | Chief Development Officer | Jan 29, 2024 | Sale | $64.14 | 279 | 17,895 | 58,179 | Jan 31, 2024, 04:23 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Eisele Jeffrey | Chief Development Officer | Jan 30, 2024 | Sale | $65.53 | 971 | 63,630 | 57,208 | Jan 31, 2024, 04:23 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 29, 2024 | Sale | $64.14 | 874 | 56,057 | 1,117,131 | Jan 31, 2024, 04:21 PM |
APLS | | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 29, 2024 | Sale | $64.14 | 367 | 23,539 | 65,203 | Jan 31, 2024, 04:18 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Lewis Karen | Chief People Officer | Jan 23, 2024 | Sale | $63.69 | 4,286 | 272,975 | 47,637 | Jan 24, 2024, 04:06 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Eisele Jeffrey | Chief Development Officer | Jan 23, 2024 | Sale | $63.69 | 7,378 | 469,905 | 58,458 | Jan 24, 2024, 04:03 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 22, 2024 | Sale | $65.00 | 13,431 | 872,961 | 320,467 | Jan 23, 2024, 07:28 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Jan 22, 2024 | Sale | $65.00 | 4,184 | 271,943 | 105,077 | Jan 23, 2024, 06:17 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 22, 2024 | Sale | $65.00 | 3,413 | 221,831 | 94,507 | Jan 23, 2024, 06:15 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jan 22, 2024 | Sale | $65.00 | 3,551 | 230,801 | 95,675 | Jan 23, 2024, 06:13 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Jan 22, 2024 | Sale | $65.00 | 2,593 | 168,535 | 68,342 | Jan 23, 2024, 06:11 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Lewis Karen | Chief People Officer | Jan 22, 2024 | Sale | $65.00 | 1,738 | 112,963 | 51,923 | Jan 23, 2024, 06:07 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Eisele Jeffrey | Chief Development Officer | Jan 22, 2024 | Sale | $65.00 | 1,607 | 104,449 | 65,836 | Jan 23, 2024, 06:05 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 22, 2024 | Sale | $65.00 | 3,913 | 254,329 | 1,118,005 | Jan 23, 2024, 06:03 PM |
APLS | | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 22, 2024 | Sale | $65.00 | 1,384 | 89,954 | 65,570 | Jan 23, 2024, 06:01 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Chopas James George | VP/Chief Accounting Officer | Jan 22, 2024 | Sale | $65.00 | 1,061 | 68,961 | 39,067 | Jan 23, 2024, 06:00 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Eisele Jeffrey | Chief Development Officer | Jan 17, 2024 | Sale | $65.58 | 5,207 | 341,475 | 67,443 | Jan 18, 2024, 04:55 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Lewis Karen | Chief People Officer | Jan 17, 2024 | Sale | $65.58 | 3,276 | 214,840 | 53,661 | Jan 18, 2024, 04:54 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 16, 2024 | Sale | $66.81 | 1,632 | 109,032 | 1,121,918 | Jan 17, 2024, 04:47 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Chopas James George | VP/Chief Accounting Officer | Jan 16, 2024 | Sale | $66.81 | 864 | 57,723 | 40,128 | Jan 17, 2024, 04:45 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Lewis Karen | Chief People Officer | Jan 16, 2024 | Sale | $66.81 | 1,632 | 109,032 | 56,937 | Jan 17, 2024, 04:43 PM |
APLS | | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 16, 2024 | Sale | $66.81 | 1,631 | 108,965 | 66,954 | Jan 17, 2024, 04:41 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Jan 16, 2024 | Sale | $66.81 | 1,857 | 124,064 | 70,935 | Jan 17, 2024, 04:40 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Jan 16, 2024 | Sale | $66.81 | 4,240 | 283,268 | 109,261 | Jan 17, 2024, 04:38 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 16, 2024 | Sale | $66.81 | 2,235 | 149,317 | 97,920 | Jan 17, 2024, 04:37 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jan 16, 2024 | Sale | $66.81 | 2,235 | 149,317 | 99,226 | Jan 17, 2024, 04:36 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 16, 2024 | Sale | $66.81 | 7,851 | 524,514 | 333,898 | Jan 17, 2024, 04:32 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Eisele Jeffrey | Chief Development Officer | Jan 16, 2024 | Sale | $66.81 | 438 | 29,262 | 72,650 | Jan 17, 2024, 12:24 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Baumal Caroline | Chief Medical Officer | Jan 04, 2024 | Sale | $60.05 | 2,751 | 165,207 | 32,931 | Jan 05, 2024, 04:14 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Eisele Jeffrey | Chief Development Officer | Dec 26, 2023 | Sale | $57.86 | 68 | 3,935 | 53,815 | Dec 28, 2023, 04:13 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Eisele Jeffrey | Chief Development Officer | Dec 27, 2023 | Sale | $60.23 | 235 | 14,154 | 53,580 | Dec 28, 2023, 04:13 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Dec 19, 2023 | Sale | $28.19 | 11,810 | 332,956 | 93,658 | Dec 20, 2023, 04:18 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Director | Dec 14, 2023 | Option Exercise | $13.19 | 6,274 | 82,754 | 128,677 | Dec 15, 2023, 04:04 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | Chief Research Officer | Dec 01, 2023 | Sale | $36.93 | 20,000 | 738,500 | 78,299 | Dec 05, 2023, 07:40 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Dec 01, 2023 | Sale | $37.95 | 220,000 | 8,349,203 | 186,407 | Dec 05, 2023, 07:29 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Director | Dec 01, 2023 | Sale | $61.13 | 24,000 | 1,467,240 | 192,679 | Dec 05, 2023, 04:21 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Nov 30, 2023 | Sale | $32.38 | 28,316 | 916,889 | 91,871 | Dec 01, 2023, 04:11 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Nov 21, 2023 | Sale | $48.80 | 5,000 | 244,000 | 269,655 | Nov 21, 2023, 05:36 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Director | Nov 17, 2023 | Sale | $49.99 | 8,894 | 444,620 | 122,403 | Nov 21, 2023, 04:36 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Director | Oct 17, 2023 | Sale | $49.00 | 24,000 | 1,176,000 | 216,679 | Nov 21, 2023, 04:00 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | Nov 17, 2023 | Option Exercise | $25.21 | 2,500 | 63,013 | 368,670 | Nov 20, 2023, 04:18 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Nov 14, 2023 | Option Exercise | $3.76 | 45,000 | 169,200 | 1,116,807 | Nov 15, 2023, 04:10 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Nov 08, 2023 | Sale | $20.82 | 29,494 | 613,949 | 1,083,807 | Nov 09, 2023, 04:18 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Chopas James George | VP/Chief Accounting Officer | Oct 23, 2023 | Sale | $46.04 | 132 | 6,077 | 32,680 | Oct 24, 2023, 04:20 PM |
APLS | | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Oct 23, 2023 | Sale | $46.04 | 131 | 6,031 | 51,622 | Oct 24, 2023, 04:18 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | Oct 17, 2023 | Sale | $25.59 | 2,500 | 63,963 | 368,670 | Oct 18, 2023, 05:43 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Oct 09, 2023 | Sale | $17.51 | 30,500 | 533,955 | 1,078,313 | Oct 10, 2023, 04:26 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | Sep 18, 2023 | Sale | $23.84 | 2,500 | 59,588 | 368,670 | Sep 19, 2023, 05:05 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Sep 18, 2023 | Sale | $39.58 | 30,069 | 1,190,051 | 73,634 | Sep 19, 2023, 05:03 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | Sep 15, 2023 | Option Exercise | $24.01 | 2,500 | 60,013 | 368,670 | Sep 18, 2023, 04:24 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Sep 08, 2023 | Sale | $18.49 | 30,500 | 563,835 | 1,071,813 | Sep 11, 2023, 04:58 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | Chief Research Officer | Sep 06, 2023 | Sale | $43.01 | 1,756 | 75,526 | 68,299 | Sep 07, 2023, 04:08 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Chopas James George | VP/Chief Accounting Officer | Aug 31, 2023 | Sale | $41.23 | 551 | 22,716 | 30,312 | Sep 01, 2023, 04:08 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Sep 01, 2023 | Sale | $15.70 | 450,000 | 7,063,959 | 574,655 | Sep 01, 2023, 04:05 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Aug 08, 2023 | Option Exercise | $10.93 | 30,500 | 333,315 | 1,065,313 | Aug 09, 2023, 04:08 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | Jul 21, 2023 | Option Exercise | $2.67 | 49,779 | 132,910 | 367,420 | Jul 24, 2023, 05:01 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | Jul 20, 2023 | Option Exercise | $2.67 | 50,000 | 133,500 | 317,641 | Jul 21, 2023, 04:13 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | Jul 17, 2023 | Option Exercise | $33.73 | 2,500 | 84,325 | 268,891 | Jul 18, 2023, 04:40 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jul 10, 2023 | Option Exercise | $34.89 | 30,500 | 1,063,995 | 1,058,813 | Jul 11, 2023, 05:37 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Jul 03, 2023 | Sale | $89.98 | 8,510 | 765,730 | 85,753 | Jul 06, 2023, 04:20 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jul 03, 2023 | Sale | $50.00 | 13,558 | 677,921 | 84,492 | Jul 06, 2023, 04:16 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | Jun 20, 2023 | Option Exercise | $45.54 | 2,500 | 113,850 | 268,891 | Jun 21, 2023, 04:34 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jun 08, 2023 | Option Exercise | $37.56 | 30,500 | 1,145,595 | 1,052,313 | Jun 09, 2023, 04:40 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jun 05, 2023 | Sale | $49.42 | 139,558 | 6,896,410 | 147,492 | Jun 06, 2023, 04:59 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Lewis Karen | Chief People Officer | Jun 01, 2023 | Sale | $60.06 | 10,000 | 600,550 | 46,504 | Jun 02, 2023, 04:40 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | May 17, 2023 | Option Exercise | $45.67 | 2,500 | 114,163 | 268,891 | May 18, 2023, 05:12 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | May 16, 2023 | Sale | $44.17 | 60,000 | 2,650,000 | 304,655 | May 18, 2023, 05:10 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | May 17, 2023 | Option Exercise | $2.67 | 20,000 | 53,400 | 294,655 | May 18, 2023, 05:10 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | May 08, 2023 | Option Exercise | $37.97 | 30,500 | 1,158,075 | 1,045,813 | May 09, 2023, 05:02 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | May 03, 2023 | Option Exercise | $48.90 | 10,000 | 489,000 | 80,995 | May 04, 2023, 04:40 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Apr 19, 2023 | Option Exercise | $2.67 | 20,000 | 53,400 | 657,601 | Apr 20, 2023, 04:51 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Apr 18, 2023 | Sale | $42.35 | 60,000 | 2,540,820 | 667,601 | Apr 20, 2023, 04:51 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Machiels Alec | Director | Apr 17, 2023 | Sale | $41.86 | 2,500 | 104,650 | 268,891 | Apr 18, 2023, 04:30 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 10, 2023 | Option Exercise | $32.39 | 30,500 | 987,915 | 1,039,313 | Apr 11, 2023, 04:20 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Director | Apr 03, 2023 | Sale | $74.05 | 500 | 37,025 | 131,297 | Apr 05, 2023, 04:54 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Lewis Karen | Chief People Officer | Apr 03, 2023 | Sale | $54.56 | 10,000 | 545,550 | 46,430 | Apr 05, 2023, 04:52 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Apr 03, 2023 | Sale | $44.57 | 10,000 | 445,700 | 80,995 | Apr 05, 2023, 04:50 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 21, 2023 | Option Exercise | $32.71 | 60,000 | 1,962,432 | 1,174,591 | Mar 23, 2023, 04:55 PM |
APLS | | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 22, 2023 | Option Exercise | $4.16 | 127,221 | 529,411 | 1,271,812 | Mar 23, 2023, 04:55 PM |